New N,N '-bis(4-((4-alkoxybenzoyl)oxy)phenyl)-1,4-diaza-1,3-butadiene (L) ligands, obtained by condensation of 4-((alkoxybenzoyl)oxy)anilines and glyoxal, were complexed to different [ReX(CO)(3)] fragments to give the complexes [ReX(L)(CO)(3)] (X = Cl, Br, I) and [Re(CF(3)SO(3))(L)(CO)(3)].THF. The chloro and bromo complexes were obtained by direct reaction of the ligands with [ReX(CO)(5)] (X = Cl, Br), while the iodo and triflato derivatives were obtained via metathesis of the chloro or bromo precursors with potassium iodide or silver triflate respectively. The liquid-crystalline behavior of the ligands and the related rhenium complexes has been studied by means of optical microscopy, differential scanning calorimetry, and small angle X-ray diffraction. Nematic and smectic C phases were observed when the coordinated counteranions were Cl, Br, and I, respectively; the triflato derivatives were not mesomorphic.
No takes yet. Share an insight, caveat, or question.
Morrone et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: